Omalizumab safely manages Chronic spontaneous urticaria during pregnancy
Treating a pregnant patient with chronic spontaneous urticaria (CSU) can be quite challenging. According to recent findings, most CSU treatments for pregnant patients involved the use of second-generation H1-antihistamines (sgAHs), while information on the safety of Omalizumab is limited. A study found Omalizumab to be a safe treatment option for pregnant women with a history […]